Cliff Asness’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Cliff Asness’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.55M	Buy	22,421 +10,571	+89%	+$1.43M	﹤0.01%	2228
2026 Q1	$1.51M	Buy	11,850 +1,536	+15%	+$192K	﹤0.01%	2537
2025 Q4	$1.26M	Buy	10,314 +2,926	+40%	+$335K	﹤0.01%	2429
2025 Q3	$740K	Buy	7,388 +576	+8%	+$51.9K	﹤0.01%	2602
2025 Q2	$565K	Buy	6,812 +1,834	+37%	+$146K	﹤0.01%	2549
2025 Q1	$404K	Buy	4,978 +2,167	+77%	+$194K	﹤0.01%	2548
2024 Q4	$253K	Buy	+2,811	New	+$272K	﹤0.01%	2577

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Cliff Asness's XBI Position: Q2 2026 in Review

Cliff Asness increased its State Street SPDR S&P Biotech ETF (XBI) stake by 89% in Q2 2026, buying an estimated $1.43M and bringing the position to 22,421 shares worth $3.55M. The position accounts for ﹤0.01% of the portfolio, ranked #2228.

Cliff Asness first reported a position in XBI in Q4 2024 and has held it in 7 quarters since. 931 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Cliff Asness held 22,421 shares of State Street SPDR S&P Biotech ETF worth $3.55M as of Q2 2026.
Cliff Asness bought 10,571 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $1.43M.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #2228 holding.
Cliff Asness first reported a position in State Street SPDR S&P Biotech ETF in Q4 2024 and has held it in 7 quarters since.
931 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.